PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Jun Miyakoshi
raw_affiliation_strings: Department of Respiratory Medicine, Chiba University, Chiba, Chiba, Japan
Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Tatsuya Yoshida
raw_affiliation_strings: Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Yuji Uehara
raw_affiliation_strings: Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Department of Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan
raw_author_name: Yuki Takeyasu
raw_affiliation_strings: Department of Respiratory Medicine, Kansai Medical University Hospital, Hirakata, Japan
raw_author_name: Masayuki Shirasawa
raw_affiliation_strings: Department of Respiratory Medicine, Kitasato University Hospital, Sagamihara, Kanagawa, Japan
raw_author_name: Akito Fukuda
raw_affiliation_strings: Division of Cancer Immunology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Jumpei Kashima
raw_affiliation_strings: Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Shogo Kumagai
raw_affiliation_strings: Division of Cancer Immunology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Hidehito Horinouchi
raw_affiliation_strings: Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Hanako Ono
raw_affiliation_strings: Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Kouya Shiraishi
raw_affiliation_strings: Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Takashi Kohno
raw_affiliation_strings: Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
raw_author_name: Shunsuke Kondo
raw_affiliation_strings: Department of Chemotherapy and Palliative Care, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan
Department of Chemotherapy and Palliative Care, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan
raw_author_name: Yasushi Goto
raw_affiliation_strings: Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Noboru Yamamoto
raw_affiliation_strings: Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Yasushi Yatabe
raw_affiliation_strings: Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
raw_author_name: Yukio Hosomi
raw_affiliation_strings: Department of Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan
raw_author_name: Takayasu Kurata
raw_affiliation_strings: Department of Respiratory Medicine, Kansai Medical University Hospital, Hirakata, Japan
raw_author_name: Katsuhiko Naoki
raw_affiliation_strings: Department of Respiratory Medicine, Kitasato University Hospital, Sagamihara, Kanagawa, Japan
raw_author_name: Takuji Suzuki
raw_affiliation_strings: Department of Respiratory Medicine, Chiba University, Chiba, Chiba, Japan
raw_author_name: Yuichiro Ohe
raw_affiliation_strings: Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan